Abiopharma

🔍 Zelnick Kaufman Beth (Executive)

Company: CorMedix Inc. (CRMD)

Report Date: 2025-08-29

Detailed Transactions and Holdings:

• Acquired 69,686 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 189,298.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares represent restricted stock units granted on 08/29/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vested 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.